iCo Therapeutics, Inc.

iCo Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: Canada

: | OTC Markets: ICOTF | TSX Venture Exchange: ICO

Similar to: Skystar Bio-Pharmaceutical Co., United-Guardian, Inc., Cephalon, Inc.

iCo Therapeutics, Inc. is a biotechnology company, which is focused on the identification, development and commercialization of drug candidates that treat sight and life threatening diseases through a development-only business model. It focus on in-licenses and redefines existing drug candidates clinical history and redose, reformulate and develop drug candidates for the treatment of sight-threatening conditions such as diabetic macular edema and severe allergic conjunctivitis and life threatening diseases such as severe systemic fungal infections. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, Canada.

News & Analysis

You may also be interested in: